BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9660604)

  • 1. The cervical screening muddle.
    Slater D
    Lancet; 1998 Apr; 351(9109):1130. PubMed ID: 9660604
    [No Abstract]   [Full Text] [Related]  

  • 2. The screening muddle.
    Lancet; 1998 Feb; 351(9101):459. PubMed ID: 9482430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening of cervical cancer, false negative smears].
    Vassilakos P; de Marval F; Muñoz M
    Rev Med Suisse Romande; 1998 Jan; 118(1):97. PubMed ID: 9580199
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening of cervical cancer, false negative vaginal smears].
    Weintraub D
    Rev Med Suisse Romande; 1997 Nov; 117(11):921. PubMed ID: 9471658
    [No Abstract]   [Full Text] [Related]  

  • 5. Cervical screening.
    Lancet; 1989 Sep; 2(8663):627-9. PubMed ID: 2570326
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical screening: making it better.
    Quek SC; Singer A
    Practitioner; 1999 Jun; 243(1599):441. PubMed ID: 10476562
    [No Abstract]   [Full Text] [Related]  

  • 8. The cervical screening muddle.
    Thornton H
    Lancet; 1998 Apr; 351(9109):1130-1. PubMed ID: 9660605
    [No Abstract]   [Full Text] [Related]  

  • 9. The cervical screening muddle.
    Sutton G
    Lancet; 1998 Apr; 351(9109):1129. PubMed ID: 9660602
    [No Abstract]   [Full Text] [Related]  

  • 10. The cervical screening muddle.
    Herbert A
    Lancet; 1998 Apr; 351(9109):1129-30. PubMed ID: 9660603
    [No Abstract]   [Full Text] [Related]  

  • 11. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 12. The cervical screening muddle.
    Womack C; Warren AY
    Lancet; 1998 Apr; 351(9109):1129. PubMed ID: 9660601
    [No Abstract]   [Full Text] [Related]  

  • 13. Pap smear refined.
    Oncology (Williston Park); 1997 Aug; 11(8):1125. PubMed ID: 9268975
    [No Abstract]   [Full Text] [Related]  

  • 14. The pitfalls of cervical cancer screening.
    Sedlis A
    Contrib Gynecol Obstet; 1991; 18():103-14. PubMed ID: 1657521
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervical cancer control--Rhode Island.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Sep; 38(38):659-62. PubMed ID: 2506415
    [No Abstract]   [Full Text] [Related]  

  • 16. Report of a national workshop on screening for cancer of the cervix.
    Anderson GH
    CMAJ; 1992 Apr; 146(8):1280; author reply 1280, 1284-5. PubMed ID: 1555154
    [No Abstract]   [Full Text] [Related]  

  • 17. Reasons that some screening programmes fail to control cervical cancer.
    Chamberlain J
    IARC Sci Publ; 1986; (76):161-8. PubMed ID: 3570402
    [No Abstract]   [Full Text] [Related]  

  • 18. Pitfalls in the screening and early diagnosis of cervical cancer.
    Wain GV; Hacker NF
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):74-9. PubMed ID: 2102310
    [No Abstract]   [Full Text] [Related]  

  • 19. Quality control in Papanicolaou tests.
    Wachtel M
    Am J Clin Pathol; 2002 Nov; 118(5):804; author reply 805. PubMed ID: 12428803
    [No Abstract]   [Full Text] [Related]  

  • 20. Papanicolaou cervical smears for screening in asymptomatic women.
    Barnes BA
    Prim Care; 1981 Mar; 8(1):131-40. PubMed ID: 6911755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.